This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss·Investor's Business Daily
In this article:

Edwards Lifesciences stock underperformed its peers on Friday, sliding on light sales of its transcatheter aortic heart-valve replacements.

Advertisement